Search Results - "Jia, Jinsong"

Refine Results
  1. 1

    Porcine antilymphocyte globulin versus rabbit antithymocyte globulin for intensive immunosuppressive therapy of acquired aplastic anemia: A meta-analysis and systematic review by Jia, Jinsong, Wang, Shasha, Kang, Ying, Liu, Xiujuan, Xu, Lanping

    “…Objective: Several studies have reported that porcine antilymphocyte globulin (pALG) has a significant effect on aplastic anemia (AA), but their conclusions…”
    Get full text
    Journal Article
  2. 2

    Transfusion-dependent non-severe aplastic anemia: characteristics and outcomes in the clinic by Zhang, Yawen, He, Yao, Wang, Suli, Sun, Jingnan, Jia, Jinsong, Gong, Yuemin, He, Guangsheng, Li, Jianyong

    Published in Frontiers in immunology (11-07-2023)
    “…Transfusion-dependent non-severe aplastic anemia (TD-NSAA) is a rare condition of bone marrow failure that can persist for a long time or develop into severe…”
    Get full text
    Journal Article
  3. 3

    Prolonged use of eltrombopag in patients with severe aplastic anemia in the real world by Li, Ruixin, Wang, Ningling, Chai, Xingxing, Yang, Linhai, Liu, Kangkang, He, Hailong, Lin, Shengyun, Yang, Yan, Jia, Jinsong, Zhang, Donghua, Gong, Yuemin, Shi, Jinning, He, Guangsheng, Li, Jianyong

    Published in Clinical and experimental medicine (01-10-2023)
    “…Eltrombopag (EPAG) can improve the efficacy of immunosuppressive therapy (IST) consisting of antithymocyte immunoglobulin (ATG) and cyclosporin in severe…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Predicting Response of Severe Aplastic Anemia to Rabbit-Antithymocyte Immunoglobulin Based Immunosuppressive Therapy Combined With Eltrombopag by Li, Ruixin, Zhou, Jiongtao, Liu, Zhengyuan, Chen, Xi, Long, Qiqiang, Yang, Yan, Lin, Shengyun, Jia, Jinsong, He, Guangsheng, Li, JianYong

    Published in Frontiers in immunology (26-05-2022)
    “…Addition of eltrombopag (E-PAG) to intensive immunosuppressive therapy (IST) contributes to restoring hematopoiesis in patients with severe aplastic anemia…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Rapid diagnosis of Aspergillus flavus infection in acute very severe aplastic anemia with metagenomic next-generation sequencing: a case report and literature review by Kang, Ying, Zhang, Xiaojing, Qin, Cao, Zheng, Yafeng, Gai, Wei, Jia, Xiaofei, Shao, Bo, Zhang, Shuai, Jiang, Hao, Huang, XiaoJun, Jia, Jinsong

    Published in Frontiers in medicine (23-09-2024)
    “…Infection remains the leading cause of mortality in severe aplastic anemia (SAA) patients, with invasive fungal infections being the great threat. accounts for…”
    Get full text
    Journal Article
  8. 8

    Patients with AML-MRC benefit from decitabine in combination with low-dose G-CSF, cytarabine and aclarubicin: A single center cohort study by Liu, Jing, Liu, Xiaohong, Jia, Jinsong, Gong, Lizhong, Lu, Shengye, Wang, Jing, Huang, Xiao-jun, Jiang, Hao

    Published in Leukemia research reports (01-01-2022)
    “…Patients with acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) are insensitive to conventional chemotherapy and, therefore, have a poor…”
    Get full text
    Journal Article
  9. 9

    Decitabine in patients with myelodysplastic syndromes: A multi‐center, open‐label, dose comparison trial by Liu, Hui, Jiang, Hao, Tong, Hongyan, Xia, Ruixiang, Yang, Linhua, Zhao, Hongguo, Ouyang, Jian, Bai, Hai, Sun, Hui, Hou, Li, Jiang, Ming, Zeng, Yun, Liu, Zhuogang, Liang, Aibin, Xie, Yinghua, Yu, Kang, Zhai, Zhimin, Liu, Li, Jia, Jinsong, Fu, Rong, Shao, Zonghong

    Published in Cancer medicine (Malden, MA) (01-07-2023)
    “…Background The hypomethylating agent decitabine is the standard therapy for intermediate or high risk myelodysplastic syndrome (MDS). Methods In this trial,…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Assessing the efficiency and significance of Methylated DNA Immunoprecipitation (MeDIP) assays in using in vitro methylated genomic DNA by Jia, Jinsong, Pekowska, Aleksandra, Jaeger, Sebastien, Benoukraf, Touati, Ferrier, Pierre, Spicuglia, Salvatore

    Published in BMC research notes (16-09-2010)
    “…DNA methylation contributes to the regulation of gene expression during development and cellular differentiation. The recently developed Methylated DNA…”
    Get full text
    Journal Article
  13. 13

    Fractional-order super-twisting sliding mode attitude control for elastic refueling boom with exogenous disturbances by Zhao, Wenbi, Jia, Jinsong, Qu, Yaohong, Yu, Ziquan, Zhang, Youmin

    Published in Nonlinear dynamics (01-07-2024)
    “…During the aerial refueling alignment phase, the slender refueling boom is prone to elastic deformation under random exogenous disturbances, which deteriorates…”
    Get full text
    Journal Article
  14. 14

    Outcome of Standard Immunosuppressive Therapy with or without Eltrombopag for Chinese Patients with Severe Aplastic Anemia in the Real World by JIA, Jinsong, Jiang, Hao, Huang, Xiao Jun

    Published in Blood (13-11-2019)
    “…BACKGROUND Immunosuppression is the current standard therapy for patients with severe aplastic anemia(SAA), whereas allogeneic haematopoietic stem cell…”
    Get full text
    Journal Article
  15. 15
  16. 16

    A real-word experience of eltrombopag plus rabbit antithymocyte immunoglobulin-based IST in Chinese patients with severe aplastic anemia by Jin, Yuanyuan, Li, Ruixin, Lin, Shengyun, Jia, Jinsong, Yang, Yan, Zhang, Donghua, He, Guangsheng, Li, Jiangyong

    Published in Annals of hematology (01-11-2022)
    “…Eltrombopag (EPAG), a thrombopoietin receptor agonist, was approved for the treatment of severe aplastic anemia (SAA) combined with immunosuppressive therapy…”
    Get full text
    Journal Article
  17. 17

    Intensive Immunosupressive Therapy Combining with Eltrombopag for Adult Chinese Patients with Severe Aplastic Anemia by Li, Ruixin, Jin, Yuanyuan, Jia, Jinsong, Lin, Shengyun, Yang, Yan, He, Guangsheng, Li, Jianyong

    Published in Blood (23-11-2021)
    “…In sight of different pharmacokinetics between races, the recommended dose is 75mg/d for Asian using eltrombopag [1]. However, the efficacy and safety of…”
    Get full text
    Journal Article
  18. 18

    Anti-PD-1 Antibody (Sintilimab) Plus Decitabine As First Line Treatment for Patients with Higher-Risk Myelodysplastic Syndrome (MDS): Primary Results from a Single-Arm,Open-Label,Phase II Study by Wang, Jing, Li, Siqi, Jiang, Hao, Chang, Ying-Jun, Zhao, Xiao-su, JIA, Jinsong, Zhu, Xiaolu, Gong, Lizhong, Liu, Xiaohong, Yu, Wen-Jing, Huang, Xiaojun

    Published in Blood (02-11-2023)
    “…Background: Hypomethylating agents (HMAs) are the preferred treatment for untreated patients with higher-risk Myelodysplastic Syndrome (MDS). However, the…”
    Get full text
    Journal Article
  19. 19
  20. 20

    A real-world experience of eltrombopag plus rabbit antithymocyte immunoglobulin–based IST in Chinese patients with severe aplastic anemia by Jin, Yuanyuan, Li, Ruixin, Lin, Shengyun, Jia, Jinsong, Yang, Yan, Zhang, Donghua, He, Guangsheng, Li, Jiangyong

    Published in Annals of hematology (01-11-2022)
    “…Eltrombopag (EPAG), a thrombopoietin receptor agonist, was approved for the treatment of severe aplastic anemia (SAA) combined with immunosuppressive therapy…”
    Get full text
    Journal Article